CEL-SCI Corporation reported its financial results for the three months ended December 31, 2024, on February 14, 2025. The company recorded a net loss of $7.1 million for the quarter, compared to a net loss of $6.7 million in the prior year period.
Research and development expenses for the quarter were $4.4 million, remaining approximately consistent with the three months ended December 31, 2023. General and administrative expenses increased to $2.5 million from $2.1 million in the comparable prior year quarter.
Net loss per common share narrowed by 21% to $0.11 for the three months ended December 31, 2024, compared to $0.14 for the prior year period. The company utilized $5.1 million in cash during the quarter.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.